STTK NASDAQ
Shattuck Labs, Inc.
1W: -1.2%
1M: -10.3%
3M: -14.6%
YTD: +55.5%
1Y: +200.5%
3Y: +312.1%
5Y: -70.8%
$5.77
+0.23 (+4.15%)
Pre-Market: $5.60 (-0.17, -2.95%)
Weekly Expected Move ±10.7%
$4
$5
$5
$6
$7
Credit Risk of going bust: lower than 74% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Shattuck Labs, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $579.1M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $900K (short-term plus half of long-term), stock volatility 75.8%; Altman Z'' 20.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Shattuck Labs, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $579.1M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $900K (short-term plus half of long-term), stock volatility 75.8%; Altman Z'' 20.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (54)
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Has Consensus Target Price of $13.70 According to Analysts
Nektar, Protagonist, Shattuck are Leerink top picks in emerging immunology
Shattuck Labs (NASDAQ:STTK) Stock Falls 5.3% – Should You Sell?
Shattuck Labs (NASDAQ:STTK) Shares Climb 11.9% – Here’s Why
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Has Consensus Price Target of $12.78 According to Analysts
Bank of America Corp DE Cuts Holdings in Shattuck Labs, Inc. $STTK
3,750,000 Shares in Shattuck Labs, Inc. $STTK Purchased by Frazier Life Sciences Management L.P.
BlackRock Inc. Invests $27.32 Million in Shattuck Labs, Inc. $STTK
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $12.78 Consensus PT from Analysts
What Shattuck Labs Stock Topped the Market on Monday
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
Q3 EPS Estimates for Shattuck Labs Boosted by HC Wainwright
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Brokerages Set Shattuck Labs, Inc. (NASDAQ:STTK) Target Price at $12.62
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $11.00 Average PT from Brokerages
12 Health Care Stocks Moving In Friday's Intraday Session
What's Going On With Shattuck Labs Stock Wednesday?
Shattuck Labs drops 6%, prices $75M share raise at $4 per share
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
Shattuck Labs launches proposed public offering of common stock
Shattuck Labs, Inc. Announces Proposed Public Offering
Why Is Shattuck Labs Stock Trading Lower On Monday?
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings
Shattuck Labs Announces Phase 1 Results for SL-325
12 Health Care Stocks Moving In Friday's After-Market Session
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On Friday
Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Shattuck Labs GAAP EPS of -$0.13 in-line
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
12 Health Care Stocks Moving In Wednesday's After-Market Session
Shattuck Labs Q1 EPS Forecast Increased by HC Wainwright
Aberdeen Group plc Buys 436,673 Shares of Shattuck Labs, Inc. $STTK
Analysts Set Shattuck Labs, Inc. (NASDAQ:STTK) Target Price at $10.50
Analysts Set Shattuck Labs, Inc. (NASDAQ:STTK) Target Price at $10.00
HC Wainwright Comments on Shattuck Labs Q1 Earnings
Why Shattuck Labs Stock Soared More Than 53% Higher This Week
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Large Drop in Short Interest
Shattuck Labs GAAP EPS of -$0.12 beats by $0.01
Insights into Shattuck Labs Q4 Earnings
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $6.20 Consensus PT from Analysts
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Large Growth in Short Interest
Why Shattuck Labs Stock Soared in December
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy
Shattuck Labs to Participate in Upcoming December Investor Conferences